Immediate Impact
22 standout
Citing Papers
Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk‐Stratification, and Management
2025 Standout
GPCR drug discovery: new agents, targets and indications
2025 Standout
Works of Corine Baayen being referenced
A Randomized, Double‐Blind , Controlled Phase II Study of Foliglurax in Parkinson's Disease
2022
A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Corine Baayen | 76 | 10 | 12 | 145 | 104 | 17 | 304 | |
| Klára Gadó | 13 | 1 | 102 | 95 | 25 | 285 | ||
| Celaletdin Camcı | 34 | 1 | 26 | 62 | 24 | 313 | ||
| Debra M. Prow | 50 | 2 | 2 | 66 | 41 | 13 | 263 | |
| C Praga | 29 | 1 | 87 | 46 | 26 | 290 | ||
| Lisa Lohr | 69 | 1 | 25 | 30 | 12 | 309 | ||
| Merete Kjær Hansen | 153 | 1 | 12 | 74 | 14 | 358 | ||
| Habib Haybar | 36 | 23 | 96 | 28 | 304 | |||
| Sergi Torramadé‐Moix | 29 | 51 | 96 | 20 | 358 | |||
| Katsuhiro Fukutake | 36 | 92 | 99 | 16 | 321 | |||
| J Nafziger | 24 | 1 | 28 | 65 | 21 | 310 |
All Works
Loading papers...